Blood filter could give moms with preeclampsia more time before delivery
NCT ID NCT06464159
First seen May 09, 2026 · Last updated Jun 15, 2026 · Updated 6 times
Summary
This study tests a blood-filtering device (apheresis) to remove a harmful protein called sFlt-1 and restore a healthy balance in pregnant women with preeclampsia. The goal is to safely prolong pregnancy and reduce the risks of very early delivery. About 100 women with preeclampsia or normal pregnancies will participate to measure changes in key blood factors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Maternité Port-Royal
RECRUITINGParis, 75014, France
Contact
Conditions
Explore the condition pages connected to this study.